Altogether, our data support the specific use of CB2 as antitumor target27 also in BC, but we cannot exclude the involvement of other ECS receptors, such as GPR55, which may interact with JWH01528, 29 promoting cell proliferation but also apoptosis30, 31, 32. Here, CNR2 is linked to breast cancer.